Acute pancreatitis is a sudden inflammation of the pancreas that is most often caused by gallstones or excessive alcohol use. However, sometimes the cause is unknown. The symptoms include severe abdominal pain that may spread to the back, fever, nausea, vomiting and fast heart rate. With progressing severity, complications involving local tissues and distant organ systems can develop rapidly resulting in high morbidity and mortality.
The global Acute Pancreatitis Market is primarily driven by rising incidence rates of the disease, as well as increasing availability of diagnostic tests and drug treatment options. Acute pancreatitis requires immediate medical care and has no known ways to fully prevent it.
The acute pancreatitis market is estimated to be valued at USD 522.5 Mn in 2024 and is expected to reach USD 710.8 Mn by 2031, growing at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2031.
Key Takeaways
- Key players operating in the acute pancreatitis market are copyright, Abbott Laboratories, Merck, GE Healthcare, Eli Lilly and Company, Johnson & Johnson and F. Hoffmann-La Roche Ltd.
- Increasing incidence of alcohol abuse and obesity are key factors fueling the growth of acute pancreatitis across the globe. Overconsumption of alcohol is the leading cause of acute pancreatitis.
- Technological advancements in diagnosis and imaging such as magnetic resonance cholangiopancreatography (MRCP) allow earlier diagnosis and risk stratification, supporting more timely intervention and management of acute pancreatitis.
Market Trends
- Increasing research into genetic risk factors and potential new drug targets: Research is ongoing into understanding the genetic risk factors for acute pancreatitis. This could uncover new drug targets and predictive or preventive approaches.
- Growing popularity of minimally invasive surgery: For managing acute pancreatitis complications, minimally invasive techniques such as endoscopic retrograde cholangiopancreatography (ERCP) are gaining preference over traditional open surgeries as they are associated with less pain, shorter hospital stays and quicker recovery.
Market Opportunities
- Emergence of novel drug formulations: Drug makers are developing novel drug delivery systems and formulations to more effectively target pancreatic inflammation and associated pain in acute pancreatitis. This represents a significant opportunity.
- Rising medical infrastructure in emerging nations: With improving healthcare infrastructure and facilities in developing countries, there is high growth potential for acute pancreatitis diagnosis and treatment markets in these regions.
Impact of COVID-19 on Acute Pancreatitis Market Growth
The outbreak of COVID-19 pandemic has significantly impacted the growth of acute pancreatitis market worldwide. During the initial phase of lockdowns imposed across countries, diagnostic procedures and non-emergency surgeries related to acute pancreatitis were postponed to avoid the spread of virus in hospitals. This led to decline in demand for diagnosis and treatment of acute pancreatitis. However, with gradual lifting of lockdowns and resumption of healthcare facilities, the market is witnessing steady recovery.
The post-COVID scenario is expected to drive higher demand as backlog cases are addressed. With emphasis on safety protocols and preventive measures, healthcare providers are able to treat acute pancreatitis patients while minimizing infection risk. Telehealth and digital health solutions also helped doctors to remotely monitor and support patients during lockdowns. Pharmaceutical companies engaged in developing new drug formulations and biomarkers for accurate diagnosis of acute pancreatitis. Governments worldwide are allocating increased funding for healthcare infrastructure and R&D to better manage pancreatic disorders.
North America Dominates Acute Pancreatitis Market in Terms of Value
North America currently accounts for the largest share of global acute pancreatitis market in terms of revenue. This is attributed to growing prevalence of pancreatitis risk factors like obesity, high alcohol consumption and gastrointestinal disorders in the region. Moreover, presence of highly developed healthcare systems and widespread health insurance coverage enables high patient access to diagnosis and treatment in countries like US and copyright. Government support for research and availability of advanced diagnostic technologies have also propelled market growth.
Asia Pacific to Witness Fastest Growth in Acute Pancreatitis Market
Asia Pacific region is poised to emerge as the fastest growing market for acute pancreatitis during the forecast period. Improving healthcare infrastructure, rising patient awareness, increasing healthcare expenditure and economic growth are major factors driving the market in Asia Pacific countries. In addition, growing geriatric population susceptible to pancreatic diseases supplements market expansion. Large patient pool, improving access to diagnosis and treatment present lucrative opportunities for market players in Asia Pacific region.
Get more insights on: Acute Pancreatitis Market
Explore more related articles – Novel Spectrometry Platforms Set for Rapid Growth with Increasing Adoption in Healthcare and Biopharma Industries
About Author: Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)